Commercialization: Page 61
-
PharmaVoice Team/PharmaVoice
UpFront
Upfront Awards… CSL Honored for Work in Rare Diseases CSL Behring is the recipient of a 2012 European Organization for Rare Diseases Award for its work in developing and manufacturing therapies used to treat rare and serious medical conditions. One of the primary criteria for the award is a...
By Taren Grom • March 26, 2012 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
The forum for the industry executive Volume 12 • Number 4 Publisher Lisa Banket Editor Taren Grom Creative Director Marah Walsh Managing EDitor Denise Myshko Senior EDitor Robin Robinson features EDitor Kim Ribbink Contributing Editor Carolyn Gretton design associate Ariel Medel national account ...
By Taren Grom • March 26, 2012 -
PharmaVoice Team/PharmaVoice
How Does the Public View Pharma
As an industry, pharma has made tremendous contributions toward advancing medicine. Pharma companies have not only driven continued innovation but also demonstrated strong social responsibility. Many have programs in place, for example, to help even the poorest patients afford their treatments. P...
By Chris DeAngelis • Feb. 27, 2012 -
PharmaVoice Team/PharmaVoice
"Ain't No Sunshine" for Brand Managers
As the Sunshine Act kicks into effect, pharma product managers and their brand teams may feel some heat from this legislation, but there are steps that can be taken to avoid sunburn and emerge from this marketing game-changer with a healthy glow. With this legislation as the catalyst, now is the ...
By Al Reicheg • Feb. 27, 2012 -
PharmaVoice Team/PharmaVoice
In Defense of Qualitative Research
“The science of statistics is the chief instrumentality through which the progress of civilization is now measured, and by which its development hereafter will be largely controlled." — S. N. D. North, Director of the Census, 1903-1909 The Rise of Statistics It is possible to quantify what people...
By Brad Davidson • Feb. 27, 2012 -
PharmaVoice Team/PharmaVoice
Get Granular for a Better Understanding of the Competitive Landscape
Whether preparing for the introduction of a new product or assessing an in-licensing opportunity of an existing brand, companies want to evaluate the competitive landscape to determine the promotional resources that will be needed to succeed competitively. With leaner sales forces and physician a...
By Steve Corby • Feb. 27, 2012 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Connecting the Data Dots
Experts at Best Practices note that the current uncertain global economy has accentuated life-sciences executives’ need for powerful market insights to gain an edge over competitors. These companies are increasingly challenged to transform their market research departments from backward-looking s...
By Carolyn Gretton • Feb. 27, 2012 -
PharmaVoice Team/PharmaVoice
Pharma 3.0
As the industry evolves to address a new ecosystem within the complex and global drug development and commercialization arena, companies will need to be open to using new technologies, thinking, and processes to make healthcare more sustainable, affordable, and accessible; improve the efficiency ...
By PharmaVoice Team • Feb. 26, 2012 -
PharmaVoice Team/PharmaVoice
Final Phase Goal: Maximize Uptake While Speeding to Launch
In every phase of drug development today, processes are more complex and more costly than ever and the drive to reduce time and expenditure is more critical. In today’s ever-changing marketplace, this holds true especially for the last stages of the process: registration, launch, and postlaunch. ...
By PharmaVoice Team • Feb. 26, 2012 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharmaceutical POOL Dr. Anders EKBLOM Dr. Briggs MORRISON AstraZeneca Bolsters R&D Leadership Global pharmaceutical company AstraZeneca has tapped Anders Ekblom, M.D., to build and lead the science and technology integration office within the company’s R&D organization. In addition to th...
By Carolyn Gretton • Feb. 26, 2012 -
PharmaVoice Team/PharmaVoice
Social Media
Social Media Trends, Regs, and Apps Featured Briefs: Government Use of Social Media Grows First-Ever Tweet From a President Garners More Than 20,000 Responses Survey: Consumers Favor Pharma Input in Patient Communities Industry Gets More Time to Adhere to New YouTube Format TECH CHECK Apps, Twe...
By Robin Robinson • Feb. 26, 2012 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: Healogix Unveils Adaptive Toolbox Solution Group DCA Enhances Digital Detailing Solution In other technology news… E-UPGRADES AND ENHANCEMENTS Healthcare companies have struggled for years to understand how and w...
By Carolyn Gretton • Feb. 26, 2012 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: Long-Term Planning Tactics Key to Maintaining Portfolio Health Sidebar: Groups Responsible for Aligning Brand and Corporate Strategy Therapeutic Fast Trax… Other market insights… Brand Positioning Should Balance PR, RO...
By Taren Grom • Feb. 26, 2012 -
PharmaVoice Team/PharmaVoice
UpFront
Awards… » Invivodata Co-Founder wins Carnegie Science Awards Invivodata Co-founder and Chief Science Officer, Dr. Saul Shiffman has been recognized by the Carnegie Science Center as an honorable mention in the Entrepreneur Category of its 2012 Carnegie Science Awards. Dr. Shiffman is being ...
By Taren Grom • Feb. 26, 2012 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
From Molecule through Market… the vision is clear — to be successful pharmaceutical companies and their valued development partners need to understand the underlying challenges, trends, and opportunities that each molecule, compound, diagnostic, or biotech product faces as it progresses along the...
By Taren Grom • Feb. 26, 2012 -
PharmaVoice Team/PharmaVoice
Outsourcing: Enhance, Support, Grow
You cannot do today’s job with yesterday’s methods and be in business tomorrow." The wise words of Nelson Jackson should be the driving force behind every outsourcing partnership today. Implementing innovative strategies through outsourcing helps pharmaceutical companies meet the changing demands...
By Erin Neary and Dennis McLoughlin • Jan. 27, 2012 -
PharmaVoice Team/PharmaVoice
Commercialization - Decisions, Decisions, Decisions
In recent years, the research and development landscape in the pharmaceutical industry has radically changed. The search for the next big blockbuster has been replaced by the search for medicines targeted toward specific patient subpopulations or toward diseases with high unmet medical need to ma...
By Dr. Michael Ackerman • Jan. 27, 2012 -
PharmaVoice Team/PharmaVoice
Pharmaceutical Call Centers Build relationships with Healthcare Providers and Patients
Pharmaceutical, biotechnology, and medical device companies have a significant need to build relationships with prescribers and patients. However, these audiences have very different needs that require companies to take varying approaches to communicate effectively with them. Healthcare providers...
By Lou Shapiro • Jan. 27, 2012 -
PharmaVoice Team/PharmaVoice
The Emergence of Strategic Outsourcing in Clinical Supply Chain Management
Ten years ago few biopharmaceutical industry professionals could have predicted how broadly the landscape for outsourcing would change by 2012. Most companies were outsourcing in a tactical, project-by-project manner and utilizing dozens of providers across functional areas. Some were moving to a...
By Robert Dunlop • Jan. 27, 2012 -
PharmaVoice Team/PharmaVoice
Why Outsourcing Patient Enrollment to a Specialist Makes Sense
Richard Malcolm, Ph.D., CEO, Acurian Disruptive change is needed in clinical trial management, an industry where inadequate enrollment has become the biggest driver of wasted dollars. The cost of patient enrollment is now the single largest part of the total trial budget, representing 32% of the ...
By Richard Malcolm • Jan. 27, 2012 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Help from The Outside
Help from the Outside Showcase Feature: Outsourcing Carolyn Gretton As life-sciences companies look to improve operational efficiencies within their organizations, they are increasingly reducing the number of activities that they would categorize as core competencies and outsourcing them to thir...
By Carolyn Gretton • Jan. 27, 2012 -
PharmaVoice Team/PharmaVoice
Trends, Challenges, and Best Practices of Global Product Launches
Companies both large and small are expanding their global launch approach. Robin Robinson With all the variances and complexities involved in launching a product globally, especially around regulatory and approval requirements within various regions across countries, one could argue that there is...
By Robin Robinson • Jan. 27, 2012 -
PharmaVoice Team/PharmaVoice
C-Suite CROs
Insights from the C-Suite: Contract Research Organizations CRO growth continues to outpace other sectors. Frost &?Sullivan estimates that the CRO market earned revenue of $11.43 billion in 2010 and estimates that the sector will top $20.09 billion in 2017. According to a recent Frost & Su...
By Taren Grom • Jan. 27, 2012 -
PharmaVoice Team/PharmaVoice
Digital Patient-Centric Communications: Listen and Learn
Learning to listen and listening to learn are critical to a successful social networking marketing plan. While the buzzword in marketing these days is patient-centric, the industry still struggles with shifting its focus from products to consumers. Years of pushing product messaging out into the ...
By PharmaVoice Team • Jan. 27, 2012 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, marketing, And R&D?Trends affecting the healthcare industry By Carolyn Gretton Life-Sciences Companies Face Increased Complexity in Aggregate Spend Tracking and Reporting Trend: Aggregate spend mandates within the life-sciences industry are continuing to evolve in 2012 amid ongoing cha...
By Carolyn Gretton • Jan. 27, 2012
Previous
